Published in Gene Therapy Weekly, November 14th, 2002
"Most neoplasms do not induce antitumor immune responses that can control tumor growth," explained Edward De Zoeten and colleagues at the University of Illinois in Chicago. "Tumor associated antigens (TAAs) are insufficiently immunogenic. We hypothesized that the immunogenic properties of 'weak' TAAs formed by the neoplasm would be enhanced if they...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.